BABA vs TSCO

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

TSCO exhibits a stable deterministic health profile with a Piotroski F-Score of 6/9, yet it is severely overvalued relative to its Graham Number ($15.07) and Intrinsic Value ($14.42). While the company maintains an exceptional ROE of 45.18%, this is offset by negative earnings growth (-2.20% YoY) and a dangerously low Quick Ratio of 0.09, indicating heavy reliance on inventory for liquidity. The combination of a 0/100 technical trend, aggressive insider selling ($11.96M), and a price trading at a massive premium to defensive fair value suggests significant downside risk.